Literature DB >> 11306916

The monocyte/IgE connection: may polymorphisms in the CD14 gene teach us about IgE regulation?

D Vercelli1, M Baldini, F Martinez.   

Abstract

BACKGROUND: Total IgE levels are known to be under genetic control. Linkage studies have indicated that one or more loci on chromosome 5q may control total IgE, as well as asthma and bronchial hyperresponsiveness to nonspecific stimuli. Our group has undertaken a systematic analysis of chromosome 5q, and has recently characterized five single nucleotide polymorphisms at position -1619, -1359, -1145, -809 and -159 in the promoter of the gene encoding CD14, the myeloid pattern recognition receptor that is critical for efficient innate immune response to lipopolysaccharide (LPS) and bacterial ligands.
METHODS: Carriers of the major CD14 haplotypes were analyzed for serum levels of IgE and soluble CD14. In vitro IgE synthesis was assessed in peripheral blood mononuclear cells stimulated with IL-4 in the presence or absence of LPS or anti-CD14 monoclonal antibodies.
RESULTS: An inverse correlation was found between serum levels of IgE and soluble CD14. On the other hand, in vitro IL-4-dependent IgE synthesis was strongly upregulated by LPS, but suppressed by anti-CD14 monoclonal antibodies.
CONCLUSION: Our results highlight the complex role played by monocytes in IgE regulation. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306916     DOI: 10.1159/000053658

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations.

Authors:  Mamta Sharma; Jyotsna Batra; U Mabalirajan; Sangeeta Goswami; Dipyaman Ganguly; Brajen Lahkar; N K Bhatia; Amrendra Kumar; Balaram Ghosh
Journal:  Immunogenetics       Date:  2004-09-18       Impact factor: 2.846

Review 2.  Asthma from a pharmacogenomic point of view.

Authors:  C Szalai; I Ungvári; L Pelyhe; G Tölgyesi; A Falus
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

3.  CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection.

Authors:  Smanla Tundup; Leena Srivastava; Tamas Nagy; Donald Harn
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

Review 4.  The role of endotoxin and its receptors in allergic disease.

Authors:  L Keoki Williams; Dennis R Ownby; Mary J Maliarik; Christine C Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2005-03       Impact factor: 6.347

5.  Association study using combination analysis of SNP and STRP markers: CD14 promoter polymorphism and IgE level in Taiwanese asthma children.

Authors:  Jiu-Yao Wang; Ling-Mei Wang; Cherry Guan-Ju Lin; Ashely Ching-Wei Chang; Lawrence Shih-Hsin Wu
Journal:  J Hum Genet       Date:  2004-12-16       Impact factor: 3.172

6.  Polymorphisms of the CD14 gene and atopic phenotypes in Czech patients with IgE-mediated allergy.

Authors:  Dana Bučková; Lydie Izakovičová Hollá; Vladimír Znojil; Anna Vašků
Journal:  J Hum Genet       Date:  2006-09-27       Impact factor: 3.172

7.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 8.  CD14, endotoxin, and asthma risk: actions and interactions.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-07

9.  Racial differences in the association of CD14 polymorphisms with serum total IgE levels and allergen skin test reactivity.

Authors:  Zongyao Wang; John S Sundy; Catherine M Foss; Huiman X Barnhart; Scott M Palmer; Sallie D Allgood; Evan Trudeau; Katie M Alexander; Marc C Levesque
Journal:  J Asthma Allergy       Date:  2013-06-25

10.  CD14 -159 C>T gene polymorphism with increased risk of tuberculosis: evidence from a meta-analysis.

Authors:  M Y Areeshi; Raju K Mandal; Aditya K Panda; Shekhar C Bisht; Shafiul Haque
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.